Key result
Dietary flavonoids show potential antiatherogenic effects through targeted anti-inflammatory mechanisms.
Cardiovascular diseases (CVDs) are the commonest cause of global mortality and morbidity. Atherosclerosis, the fundamental pathological manifestation of CVDs, is a complex process and is poorly managed both in terms of preventive and therapeutic intervention. Aberrant lipid metabolism and chronic inflammation play critical roles in the development of atherosclerosis. These processes can be targeted for effective management of the disease. Although managing lipid metabolism is in the forefront of current therapeutic approaches, controlling inflammation may also prove to be crucial for an efficient treatment regimen of the disease. Flavonoids, the plant-derived polyphenols, are known for their antiinflammatory properties. This review discusses the possible antiatherogenic role of 3 flavonoids, namely, chrysin, quercetin, and luteolin primarily known for their antiinflammatory properties.
No takes yet. Share an insight, caveat, or question.
Basu et al. (2016) conducted a review in Atherosclerosis / Cardiovascular diseases. Dietary flavonoids (chrysin, quercetin, and luteolin) was evaluated. Dietary flavonoids chrysin, quercetin, and luteolin are reviewed for their potential antiatherogenic roles mediated through anti-inflammatory mechanisms (no quantitative outcomes reported).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: